Personalized Schizophrenia Treatment Possible with Genomic Testing

Psychiatry Advisor

Michael O'Leary

Personalized Schizophrenia Treatment Possible
with Genomic Testing

Scientists have long known that schizophrenia runs in families. The illness occurs in 1%  of the general population but in 10% of people who have a first-degree relative with the condition, according to the National Institute of Mental Health (NIMH).

People with schizophrenia tend to have higher rates of rare genetic mutations involving hundreds of different genes that may disrupt brain development, researchers have found.

However, known gene variations that contribute to schizophrenia appear to have only a small effect on disease risk. (published site)